These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19429821

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF.
    Circ Res; 1999 Jul 09; 85(1):47-56. PubMed ID: 10400910
    [Abstract] [Full Text] [Related]

  • 23. The Relaxation Properties of Myofibrils Are Compromised by Amino Acids that Stabilize α-Tropomyosin.
    Scellini B, Piroddi N, Matyushenko AM, Levitsky DI, Poggesi C, Lehrer SS, Tesi C.
    Biophys J; 2017 Jan 24; 112(2):376-387. PubMed ID: 28122223
    [Abstract] [Full Text] [Related]

  • 24. alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways.
    Wernicke D, Thiel C, Duja-Isac CM, Essin KV, Spindler M, Nunez DJ, Plehm R, Wessel N, Hammes A, Edwards RJ, Lippoldt A, Zacharias U, Strömer H, Neubauer S, Davies MJ, Morano I, Thierfelder L.
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep 24; 287(3):R685-95. PubMed ID: 15031138
    [Abstract] [Full Text] [Related]

  • 25. Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation.
    Palmiter KA, Kitada Y, Muthuchamy M, Wieczorek DF, Solaro RJ.
    J Biol Chem; 1996 May 17; 271(20):11611-4. PubMed ID: 8662805
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF.
    J Mol Cell Cardiol; 2001 Oct 17; 33(10):1815-28. PubMed ID: 11603924
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R, Petrashevskaya N, Schwartz A, Aronow B, Boivin GP, Molkentin JD, Wieczorek DF.
    Mol Cell Biochem; 2003 Sep 17; 251(1-2):33-42. PubMed ID: 14575301
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Investigations into tropomyosin function using mouse models.
    Jagatheesan G, Rajan S, Wieczorek DF.
    J Mol Cell Cardiol; 2010 May 17; 48(5):893-8. PubMed ID: 19835881
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The role of tropomyosin in the regulation of myocardial contraction and relaxation.
    Wolska BM, Wieczorek DM.
    Pflugers Arch; 2003 Apr 17; 446(1):1-8. PubMed ID: 12690456
    [Abstract] [Full Text] [Related]

  • 37. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
    McConnell M, Tal Grinspan L, Williams MR, Lynn ML, Schwartz BA, Fass OZ, Schwartz SD, Tardiff JC.
    Biochemistry; 2017 Jul 05; 56(26):3403-3413. PubMed ID: 28603979
    [Abstract] [Full Text] [Related]

  • 38. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
    Matyushenko AM, Shchepkin DV, Kopylova GV, Popruga KE, Artemova NV, Pivovarova AV, Bershitsky SY, Levitsky DI.
    Biochemistry; 2017 Jan 10; 56(1):250-259. PubMed ID: 27983818
    [Abstract] [Full Text] [Related]

  • 39. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE, Gomez CA, Hong KE, Westfall MV, Metzger JM.
    Circ Res; 2002 Aug 09; 91(3):255-62. PubMed ID: 12169652
    [Abstract] [Full Text] [Related]

  • 40. The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.
    Mirza M, Robinson P, Kremneva E, Copeland O, Nikolaeva O, Watkins H, Levitsky D, Redwood C, El-Mezgueldi M, Marston S.
    J Biol Chem; 2007 May 04; 282(18):13487-97. PubMed ID: 17360712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.